Bangkok Dusit Medical Services Public Company Limited
BDMS
Rangering i aksjer
#2107
Bangkok Dusit Medical Services Public Company Limited (BDMS) functions as a... Bangkok Dusit Medical Services Public Company Limited (BDMS) functions as a prominent healthcare conglomerate, with its subsidiaries primarily engaged in operating and owning hospitals. The company oversees a portfolio of six major hospital networks, specifically the Bangkok Hospital Group, Samitivej Hospital Group, BNH Hospital, Phyathai Hospital Group, Paolo Hospital Group, and Royal Hospital Group. Beyond providing extensive medical treatment, BDMS also offers holistic clinical wellness programs. Its diversified business interests extend to hospitality, managing hotels and restaurants, as well as retailing health and beauty products. The company provides a broad spectrum of specialized services, including laboratory testing, advanced genome sequencing, skin and aesthetic telemedicine, and air medical transportation. Additionally, BDMS delivers business-centric services such as accounting, investment management, information technology, training, various insurance solutions (including health insurance and brokerage), and property and asset management. Its operations further encompass pharmaceutical manufacturing and distribution, e-commerce, and real estate ventures. BDMS maintains a significant presence with 47 hospitals operating across Thailand and Cambodia. The company was established in 1969 and is headquartered in Bangkok, Thailand.
Aksjekurs
$0.61472129
Markedsverdi
$9.77B
Endring (1 dag)
0.00%
Endring (1 år)
-2.43%
Land
TH
Handel Bangkok Dusit Medical Services Public Company Limited (BDMS)
Kategori
Healthcare
P/E-forhold for Bangkok Dusit Medical Services Public Company Limited (BDMS)
P/E-forhold per 2026 TTM: 0
Ifølge Bangkok Dusit Medical Services Public Company Limited sine siste finansielle rapporter og aksjekurs er selskapets nåværende P/E-forhold (TTM) 0. Ved slutten av 2026 hadde selskapet en P/E på 0.
P/E-forholdshistorikk for Bangkok Dusit Medical Services Public Company Limited fra 2026 til 2026
P/E-forhold ved slutten av hvert år
| År | P/E-forhold | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
P/E-forhold for lignende selskaper eller konkurrenter
| Selskap | P/E-forhold | Forskjell i P/E-forhold | Land |
|---|---|---|---|
| 15.70 | - |
US
|
|
| - | - |
DE
|
|
| 10.40 | - |
US
|
|
| 32.07 | - |
SA
|
|
| 20.00 | - |
BR
|
Hvordan lese en P/E-ratio?
Pris/inntjening-forholdet (P/E) måler forholdet mellom aksjekursen og inntjening per aksje.
En lav men positiv P/E indikerer høy inntjening sammenlignet med nåværende verdsettelse, og kan tyde på at selskapet er undervurdert. En høy negativ (nær 0) P/E indikerer store tap.
Selskaper med P/E over 30 eller negativ betraktes vanligvis som "vekstaksjer", hvor investorer forventer vekst eller fremtidig lønnsomhet.
Selskaper med en positiv P/E under 10 anses vanligvis som "verdiaksjer", det vil si at selskapet allerede er lønnsomt, men har begrenset vekstpotensial.